摘要
Inosine monophosphate dehydrogenase (IMPDH) catalyzes the rate-limiting reaction in the de novo synthesis pathway of guanine nucleotides that is highly required for cancer cell outgrowth. Herein, we found that IMPDH isoform 2 (IMPDH2) is highly expressed in colorectal cancer (CRC) and is correlated with poor patient prognosis. Via structure-based virtual screening, we identified berberrubine, a critical ingredient of the medical plant Coptis chinensis, as a novel, selective, and competitive inhibitor of IMPDH2, which demonstrated over 15-fold selectivity to IMPDH2 than IMPDH1. Besides, we also confirmed the interaction between berberrubine and IMPDH2. Of note, berberrubine treatment significantly impairs the growth of human CRC cells in a dose-dependent manner, which can be rescued by supplementing with guanosine. Furthermore, oral administration of berberrubine remarkably reduced tumor volume and weight in a human cell line-derived xenograft model. Importantly, the anti-cancer activity of berberrubine was also confirmed by using the azoxymethane (AOM) / dextran sulfate sodium (DSS)-induced spontaneous CRC mouse model. Taken together, our study highlights that berberrubine acts as a novel IMPDH2 inhibitor, suppressing the growth of CRC in vitro and in vivo, providing a fresh perspective for its potential application in the treatment of CRC.
学科与关键词
- Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancerLi, Shi-ying; Shi, Chuan-jian; Fu, Wei-ming; Zhang, Jin-fang*Journal of Pharmacy and Pharmacology, 2023, 75(1): 129-138.被引 3
- Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2Li, Jinlian; Zheng, Shuting; Cheng, Ting; Li, Yuanyuan; Mai, Xiaobin; Jiang, Guangchun; Yang, Yongxia; Zhang, Qianqian; Li, Jiangchao; Zheng, Lingyun; Wang, Lijing*; Qi, Cuiling*Frontiers in Pharmacology, 2022, 12: 804265.被引 2
- Characterizing the Antitumor Effect of Coptis chinensis and Mume Fructus against Colorectal Cancer Based on Pharmacological AnalysisGao, RuiJiao; Lv, Ying*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 9061752.被引 4
